1887

Abstract

Herpes simplex virus type 1 (HSV-1) is a ubiquitous pathogen infecting most individuals worldwide. The majority of HSV-1-infected individuals have no clinical symptoms but shed HSV-1 asymptomatically in saliva. Recent phylogenetic analyses of HSV-1 have defined three genetic clades (A–C) and recombinants thereof. These data have all been based on clinical HSV-1 isolates and do not cover genetic variation of asymptomatically shed HSV-1. The primary goal of this study was to investigate such variation. A total of 648 consecutive saliva samples from five HSV-1-infected volunteers was collected. Asymptomatic shedding was detected on 7.6 % of the days from four subjects. The HSV-1 genome loads were quantified with real-time PCR and varied from 1×10 to 2.8×10 copies of virus DNA (ml saliva). Phylogenetic network analyses and bootscanning were performed on asymptomatically shed HSV-1. The analyses were based on DNA sequencing of the glycoprotein I gene, and also of the glycoprotein E gene for putative recombinants. For two individuals with clinical HSV-1 infection, the same HSV-1 strain was shed asymptomatically as induced clinical lesions, and sequence analyses revealed that these strains clustered distinctly to clades A and B, respectively. For one of the subjects with no clinical HSV-1 infection, a recombinant strain was identified. The other truly asymptomatic individual shed evolutionarily distinct HSV-1 strains on two occasions. The first strain was classified as a recombinant and the other strain clustered in clade A. High replication rates of different strains in the same person may facilitate the creation of recombinant clinical HSV-1 strains.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.007070-0
2009-03-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/3/559.html?itemId=/content/journal/jgv/10.1099/vir.0.007070-0&mimeType=html&fmt=ahah

References

  1. Augenbraun M., Corey L., Reichelderfer P., Wright D. J., Burns D., Koelle D. M., Robison E., Cohen M. 2001; Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women. Clin Infect Dis 33:885–890 [CrossRef]
    [Google Scholar]
  2. Bowden R., Sakaoka H., Donnelly P., Ward R. 2004; High recombination rate in herpes simplex virus type 1 natural populations suggests significant co-infection. Infect Genet Evol 4:115–123 [CrossRef]
    [Google Scholar]
  3. Bower J. R., Mao H., Durishin C., Rozenbom E., Detwiler M., Rempinski D., Karban T. L., Rosenthal K. S. 1999; Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness. J Virol 73:3843–3853
    [Google Scholar]
  4. Bruen T. C., Philippe H., Bryant D. 2006; A simple and robust statistical test for detecting the presence of recombination. Genetics 172:2665–2681
    [Google Scholar]
  5. Centifanto-Fitzgerald Y. M., Varnell E. D., Kaufman H. E. 1982; Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strains. Infect Immun 35:1125–1132
    [Google Scholar]
  6. Cowan F. M., Johnson A. M., Ashley R., Corey L., Mindel A. 1996; Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis 174:470–475 [CrossRef]
    [Google Scholar]
  7. Felsenstein J., Yokoyama S. 1976; The evolutionary advantage of recombination. II. Individual selection for recombination. Genetics 83:845–859
    [Google Scholar]
  8. Huson D. H. 1998; SplitsTree: analyzing and visualizing evolutionary data. Bioinformatics 14:68–73 [CrossRef]
    [Google Scholar]
  9. Kaufman H. E., Azcuy A. M., Varnell E. D., Sloop G. D., Thompson H. W., Hill J. M. 2005; HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci 46:241–247 [CrossRef]
    [Google Scholar]
  10. Keightley P. D., Otto S. P. 2006; Interference among deleterious mutations favours sex and recombination in finite populations. Nature 443:89–92 [CrossRef]
    [Google Scholar]
  11. Lafferty W. E., Downey L., Celum C., Wald A. 2000; Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 181:1454–1457 [CrossRef]
    [Google Scholar]
  12. Lewis M. E., Leung W. C., Jeffrey V. M., Warren K. G. 1984; Detection of multiple strains of latent herpes simplex virus type 1 within individual human hosts. J Virol 52:300–305
    [Google Scholar]
  13. Löwhagen G.-B., Tunbäck P., Andersson K., Bergström T., Johannisson G. 2000; First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect 76:179–182 [CrossRef]
    [Google Scholar]
  14. Lowhagen G. B., Bonde E., Eriksson B., Nordin P., Tunback P., Krantz I. 2002; Self-reported herpes labialis in a Swedish population. Scand J Infect Dis 34:664–667 [CrossRef]
    [Google Scholar]
  15. Mador N., Panet A., Steiner I. 2002; The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1. J Neurovirol 8:Suppl. 297–102 [CrossRef]
    [Google Scholar]
  16. Meignier B., Norrild B., Roizman B. 1983; Colonization of murine ganglia by a superinfecting strain of herpes simplex virus. Infect Immun 41:702–708
    [Google Scholar]
  17. Namvar L., Olofsson S., Bergström T., Lindh M. 2005; Detection and typing of herpes simplex virus (HSV) in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous for types 1 and 2. J Clin Microbiol 43:2058–2064 [CrossRef]
    [Google Scholar]
  18. Norberg, P., Bergström, T., Rekabdar, E., Lindh, M. & Liljeqvist, J.-A. 2004; Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses. J Virol 78:10755–10764 [CrossRef]
    [Google Scholar]
  19. Norberg P., Liljeqvist J. A., Bergstrom T., Sammons S., Schmid D. S., Loparev V. N. 2006; Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination. J Virol 80:9569–9576 [CrossRef]
    [Google Scholar]
  20. Norberg, P., Olofsson, S., Agervik Tarp, M., Clausen, H., Bergström, T. & Liljeqvist, J.-A. 2007; Glycoprotein I of herpes simplex virus type 1 contains a unique polymorphic tandem-repeated mucin region. J Gen Virol 88:1683–1688 [CrossRef]
    [Google Scholar]
  21. Roest R. W., Carman W. F., Maertzdorf J., Scoular A., Harvey J., Kant M., Van Der Meijden W. I., Verjans G. M., Osterhaus A. D. 2004; Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes. J Med Virol 73:601–604 [CrossRef]
    [Google Scholar]
  22. Sacks S. L., Griffiths P. D., Corey L., Cohen C., Cunningham A., Dusheiko G. M., Self S., Spruance S., Stanberry L. R. other authors 2004; Introduction: is viral shedding a surrogate marker for transmission of genital herpes?. Antiviral Res 63:Suppl. 1S3–S9 [CrossRef]
    [Google Scholar]
  23. Sakaoka H., Kurita K., Iida Y., Takada S., Umene K., Kim Y. T., Ren C. S., Nahmias A. J. 1994; Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J Gen Virol 75:513–527 [CrossRef]
    [Google Scholar]
  24. Scott D. A., Coulter W. A., Lamey P. J. 1997; Oral shedding of herpes simplex virus type 1: a review. J Oral Pathol Med 26:441–447 [CrossRef]
    [Google Scholar]
  25. Shimeld C., Whiteland J. L., Nicholls S. M., Grinfeld E., Easty D. L., Gao H., Hill T. J. 1995; Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J Neuroimmunol 61:7–16 [CrossRef]
    [Google Scholar]
  26. Smith J. S., Robinson N. J. 2002; Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186:Suppl. 1S3–S28 [CrossRef]
    [Google Scholar]
  27. Spruance S. L. 1984; Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity. J Clin Microbiol 19:675–679
    [Google Scholar]
  28. Tateishi K., Toh Y., Minagawa H., Tashiro H. 1994; Detection of herpes simplex virus (HSV) in the saliva from 1,000 oral surgery outpatients by the polymerase chain reaction (PCR) and virus isolation. J Oral Pathol Med 23:80–84 [CrossRef]
    [Google Scholar]
  29. Terasaki S. 1996; Latent multiple infections by herpes simplex virus type 1. Kurume Med J 43:127–136 [CrossRef]
    [Google Scholar]
  30. Theil D., Paripovic I., Derfuss T., Herberger S., Strupp M., Arbusow V., Brandt T. 2003; Dually infected (HSV-1/VZV) single neurons in human trigeminal ganglia. Ann Neurol 54:678–682 [CrossRef]
    [Google Scholar]
  31. Thiry E., Meurens F., Muylkens B., McVoy M., Gogev S., Thiry J., Vanderplasschen A., Epstein A., Keil G., Schynts F. 2005; Recombination in alphaherpesviruses. Rev Med Virol 15:89–103 [CrossRef]
    [Google Scholar]
  32. Thomas E., Lycke E., Vahlne A. 1985; Retrieval of latent herpes simplex virus type 1 genetic information from murine trigeminal ganglia by superinfection with heterotypic virus in vivo . J Gen Virol 66:1763–1770 [CrossRef]
    [Google Scholar]
  33. Tullo A. B., Shimeld C., Blyth W. A., Hill T. J., Easty D. L. 1982; Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse. J Gen Virol 63:95–101 [CrossRef]
    [Google Scholar]
  34. Umene K. 1999; Mechanism and application of genetic recombination in herpesviruses. Rev Med Virol 9:171–182 [CrossRef]
    [Google Scholar]
  35. Umene K., Yamanaka F., Oohashi S., Koga C., Kameyama T. 2007; Detection of differences in genomic profiles between herpes simplex virus type 1 isolates sequentially separated from the saliva of the same individual. J Clin Virol 39:266–270 [CrossRef]
    [Google Scholar]
  36. Whitley R., Lakeman A. D., Nahmias A., Roizman B. 1982; DNA restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med 307:1060–1062 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.007070-0
Loading
/content/journal/jgv/10.1099/vir.0.007070-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error